Quantcast

Latest Cerebral aneurysm Stories

2010-01-05 07:30:00

NATICK, Mass., Jan. 5 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has completed enrollment in its MAPS(TM) clinical trial, which is studying the coiling of intracranial aneurysms. This prospective, randomized trial commenced enrollment in 2007 and has reached its goal of 630 patients, enrolled at 47 hospitals in 11 countries. Principal investigators for the trial are Anil Gholkar, O.B.E., M.B.B.S., Clay Johnston, M.D., Ph.D., and Cameron...

2009-12-02 07:07:00

WALTHAM, Mass., Dec. 2 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, intracranial endovascular procedures to treat aneurysms will grow at over 5% through 2014 in the US. MRG's new US Markets for Transcatheter Embolization and Occlusion Devices 2010 report finds that technological advancements in embolization coils as well as imaging and coiling-assist technology will continue to drive growth in aneurysm...

2009-10-28 09:00:00

MAPLE GROVE, Minn., Oct. 28 /PRNewswire/ -- NeuroVasx, Inc., a medical device company that develops technologies for the treatment of hemorrhagic and ischemic stroke, announced today that the first procedure in Spain utilizing its cPAX Aneurysm Treatment System was performed in Madrid. cPAX received CE Mark earlier this year. Dr. Alfredo Casasco, Interventional Neuroradiology, Department of Endovascular and Percutaneous Treatment, Clinica Nuestra Senora del Rosario, used 143cm of cPAX in...

2009-08-27 10:30:50

Finnish scientists say they've determined a new treatment for patients suffering a ruptured brain aneurysm -- stent-assisted embolization -- is effective. An aneurysm is a bulge or sac that develops in a weak area of a cerebral artery wall. Hemorrhaging occurs when an aneurysm ruptures, diverting oxygen-rich blood from vital areas to the space between the brain and the skull, creating a life-threatening event. Tampere University Hospital researchers said physicians have two options -- the...

2009-08-27 07:30:00

MAPLE GROVE, Minn., Aug. 27 /PRNewswire/ -- NeuroVasx, Inc., a medical device company that develops technologies for the treatment of hemorrhagic and ischemic stroke, announced today that it has received approval to market its cPAX Aneurysm Treatment System in Canada from Health Canada's Therapeutic Products Directorate. In addition to Canadian regulatory approval, the cPAX System also received CE Mark in March 2009. Eric B. Timko, President and Chief Executive Officer of NeuroVasx,...

2009-08-26 07:51:17

Researchers in Finland have identified an effective new treatment for patients who have suffered a ruptured brain aneurysm, a potentially life-threatening event. This new technique is called stent-assisted coil embolization. An aneurysm is a bulge or sac that develops in a weak area of a cerebral artery wall. Hemorrhage occurs when an aneurysm ruptures, diverting oxygen-rich blood from vital areas to the space between the brain and the skull. The ruptured vessel can be repaired surgically or...

2009-08-25 14:36:16

Researchers in Finland have identified an effective new treatment option for patients who have suffered a ruptured brain aneurysm, a potentially life-threatening event. Results of the new study on stent-assisted coil embolization were published today in the online edition of Radiology.An aneurysm is a bulge or sac that develops in a weak area of a cerebral artery wall. Subarachnoid hemorrhage occurs when an aneurysm ruptures, diverting oxygen-rich blood from vital areas to the space between...

2009-08-20 15:39:17

The risks associated with treating a recurrent or residual brain aneurysm that was initially treated by endovascular coiling are low, according to a multicenter study led by researchers at the University of Cincinnati (UC) Neuroscience Institute. In the study of 311 patients with coiled aneurysms who underwent retreatment procedures at eight academic health centers, the risk of death or permanent major disability was slightly over one in 100, or 1.28 percent. The study is part of an...

2009-08-18 06:00:00

PALO ALTO, Calif., Aug. 18 /PRNewswire/ -- Nfocus Neuromedical Inc. announced today that the Food & Drug Administration has cleared its novel guiding catheter, the Echo(TM) Distal Access Guiding Catheter, for marketing in the US. "Nfocus works closely with key clinical opinion leaders to direct all of our design and development projects, and the Echo is our latest success story," said President and CEO Martin Dieck. "Our advisors identified the need for a guiding catheter with...

2009-08-12 06:00:00

PALO ALTO, Calif., Aug. 12 /PRNewswire/ -- Nfocus Neuromedical Inc. announced today that its CardioVasc Advantage(TM) Vascular Reconstruction Device has been granted CE Mark approval by the European Notified Body, G-Med. "The technology of the Advantage VRD is an important demonstration of Nfocus design talent and teamwork," noted company Chairman, Eric P. Milledge. "The technical platform behind this device will pave the way for future Nfocus neurovascular products currently in...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related